Apr 10 2009

Cannabis Science, Inc. Selects Product for FDA Testing

Press release: 04/09/09 Gulf Onshore Announces Name Change.

Gulf Onshore Announces Name Change to Cannabis Science, Inc. and Selection of Its First Pharmaceutical Cannabis Product for FDA Testing

ADDISON, Texas–(BUSINESS WIRE)–Gulf Onshore Inc (OTCBB: GFON.OB) has changed its name to Cannabis Science, Inc., reflecting its new business mission, and has requested a new stock trading symbol, which will be will be assigned by NASDAQ OMX in the near future. Cannabis Science Inc. has also launched its new website www.cannabisscience.com reflecting its new name.

The Company’s first pharmaceutical cannabis product for DHHS- and FDA-qualified testing will be a whole-cannabis extract in the form of a lozenge. The Company has applied for its DEA handling license and is interviewing researchers to complete and sponsor its IND (Investigational New Drug) test protocols.

The lozenge is a part of the assets and know-how developed by Steven W. Kubby and Dr. Robert J. Melamede and acquired by the Company from Cannex Therapeutics of California.

Initial findings from informal human trials using the whole-cannabis extract demonstrate the lozenge has the capacity to enhance rapid onset through oromucosal absorption. Last year, an early version of the lozenge was tested at Vancouver Island Compassion Society (VICS) (www.thevics.com), a non-profit medical cannabis organization located in Victoria, B.C, which is at the forefront of this patient-centered approach to cannabis research.

Continue reading

  • Share/Bookmark

Apr 7 2009

New Biologically Active Compounds from Cannabis

Via: ars technica:

Humans have been using cannabis for thousands of years for medical treatments, spiritual purposes, textile manufacturing, and other reasons. In recent history, chemists have isolated many cannabinoids, the metabolites in cannabis sativa, and have described some of their biological activities. For example, some cannabinoids have potent effects on multidrug resistant bacteria and others are effective against pain. The structures of known cannabinoids also inspire chemists to create synthetic chemicals to mimic certain aspects of their function, like pain reduction, while providing a powerful medical effect and avoiding negative side effects.

Although a lot of work that has been done on cannabis, scientists have not identified every cannabinoid, so many research groups are continuing to identify and categorize the chemicals in cannabis. Samir Ross from the University of Mississippi led one such group in the discovery of nine new cannabinoids, and they published the structures and biological activities of these chemicals in an advanced article in the Journal of Natural Products.

Continue reading

  • Share/Bookmark